Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. The company was founded in 2002 and is based in Heze City, China.
Metrics to compare | 300583 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300583PeersSector | |
---|---|---|---|---|
P/E Ratio | −28.9x | 30.5x | −0.5x | |
PEG Ratio | 0.07 | −0.17 | 0.00 | |
Price/Book | 1.9x | 3.2x | 2.6x | |
Price / LTM Sales | 3.5x | 4.8x | 3.3x | |
Upside (Analyst Target) | - | 15.0% | 43.5% | |
Fair Value Upside | Unlock | 4.8% | 6.8% | Unlock |